© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Payal Kohli, MD
Articles
Novel Oral Anticoagulants and Food Intake: Does It Matter?
August 19, 2013
Novel oral anticoagulants vary in bioavailability when taken with or without food.
Artificial Sweeteners-Are They Better Than Sugar?
August 14, 2013
Artificial sweeteners are associated with both weight gain and weight loss and a counterintuitive effect on human physiology.
President Bush’s Stress Test-and Stent: Guideline-Directed Care?
August 13, 2013
PCI is not recommended for asymptomatic adults who are highly functional and report no exercise-induced symptoms.
Oral Anticoagulation and Concomitant Use of Aspirin: Analysis of the ORBIT-AF Registry
August 13, 2013
Bleeding risk is increased in patients receiving oral anticoagulation and concomitant aspirin.
PTSD and Heart Disease: New Data Help Clarify the Connection
July 23, 2013
Incidence of CHD was more than double in twins diagnosed with PTSD than those without the disorder.
Low-Risk Lifestyle Protects Against Coronary Events, All-Cause Mortality
July 19, 2013
All-cause mortality was 80% lower among subjects who maintained normal weight, ate moderately, exercised, and did not smoke compared with those who followed none of these habits.
Apixaban: Effective in Acute VTE; Lower Risk of Major Bleeding
July 18, 2013
Oral apixaban for acute VTE was superior to enoxaparin followed by warfarin.
Novel Anticoagulants: Dosing Errors and Solutions
July 09, 2013
Novel anticoagulants have a half life much shorter than warfarin and so adherence and medication error are significant issues.
From Rivaroxaban to Warfarin: How to Switch, Safely
July 09, 2013
Oral anticoagulation with rivaroxaban must continue while initiating a switch to warfarin. Duration of overlap will be variable.
Novel Anticoagulants: Evidence-Based Patient Selection
July 09, 2013
Direct thrombin inhibitor dabigatran or factor Xa inhibitor apixaban or rivaroxaban? All are good choices for specific patient types.